Your session is about to expire
← Back to Search
Oral Threonine Supplementation for Infants on Tube Feeds (INFORALTHR Trial)
INFORALTHR Trial Summary
This trial is testing how much of the amino acid threonine infants need when given it orally rather than intravenously.
INFORALTHR Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowINFORALTHR Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.INFORALTHR Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 1 to 6 months old.I am taking medications that affect protein and amino acid metabolism.I am fed through a tube in my nose, stomach, or intestine.My infant is not on supplemental oxygen.I was born between 32 and 43 weeks of pregnancy.I am on a mechanical ventilator.I have a condition that affects how my body processes proteins.
- Group 1: Dietary Threonine Intake
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the opportunity to partake in this study currently available?
"Based on the info posted to clinicaltrials.gov, this medical trial is not presently accepting participants. It was initially listed back in February 2016 and last modified on January 14th 2022; however, there are still 136 other studies actively recruiting patients at present."
Do applicants of this experiment need to adhere to an age limit?
"This research is open to infant participants between 1 and 6 months old."
To what demographic is this investigation open?
"This research requires 18 neonates with hernias and diaphragmatic issues who are between 1 to 6 months old. To qualify, these infants should be clinically stable (normal vital signs & blood values) and have been born between 32–43 weeks gestation."
Share this study with friends
Copy Link
Messenger